# NLS PHARMACEUTICS LTD (NLSPW)

> Institutional ownership reported to the SEC as of Q3 2025, from Form 13F filings. Source: https://holderbook.com/stocks/NLSPW/

- Reporting holders: 3
- Reported value: $1.8K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Clear Street Group Inc.](https://holderbook.com/funds/1881567-clear-street-group-inc/) | $1.0K | 57,762 | 0.0% | 1 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](https://holderbook.com/funds/1446194-susquehanna-international-group-llp/) | $731 | 45,830 | 0.0% | 2 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $8 | 424 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2025 | 3 | $1.8K |
| Q2 2025 | 3 | $1.7K |
| Q1 2025 | 3 | $1.1K |
| Q4 2024 | 5 | $5.2K |
| Q3 2024 | 5 | $3.8K |
| Q2 2024 | 6 | $28.3K |
| Q1 2024 | 6 | $37.6K |
| Q4 2023 | 5 | $45.4K |
| Q3 2023 | 5 | $113.5K |
| Q2 2023 | 5 | $104.2K |
| Q1 2023 | 5 | $161.8K |
| Q4 2022 | 6 | $501.0K |